J2710 Neostigmine methylslfte inj

Injection, neostigmine methylsulfate, up to 0.5 mg

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for J2710

Physician Fee Schedule (CY 2026, RVU26D)

Status E: excluded from the PFS by regulation.

Payer policies and prior authorization for J2710

Payer coverage policies that name J2710

J2710 appears in 1 coverage policy from Aetna.

PayerPolicyRole in policyReviewedDocument
AetnaInjectable Medications (0020)listed, no stance (range J2550-J3520)Mar 5, 2026payer document

Medicaid fee-for-service

  • AZ: $0.70 (outpatient_hospital), effective Jan 1, 2026
  • IN: $0.10 (professional, Advanced Practice Nurse (85%), non-facility), effective Jul 1, 2024
  • KS: $0.70 (default), effective Apr 1, 2026
  • KY: $0.00 (asc), effective Jan 1, 2026
  • MS: $0.90 (comprehensive), effective Jul 1, 2026
  • NE: $0.75 (injectables), effective Jul 1, 2026
  • OH: $0.08 (provider_administered_drugs), effective Sep 1, 2013
  • OK: $0.00 (outpatient_hospital_apc), effective Jan 1, 2026
  • TX: $1.73 (nurse_practitioner_clinical_nurse_specialist, Nurse Practitioner/Clinical Nurse Specialist, non-facility), effective Sep 1, 2025
  • VA: $0.09 (medical), effective Jul 1, 2009
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WA: $0.14 (professional_administered_drugs), effective Jul 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.